Bonhomme-Faivre L - Search Results

1

MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients.

Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. Bonhomme-Faivre L, et al. Transplantation. 2004 Jul 15;78(1):21-5. doi: 10.1097/01.tp.0000130981.55654.78. Transplantation. 2004. PMID: 15257034

2

Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients.

Bonhomme-Faivre L, Picard V, Saliba F, Abbara C, Fodil M, Chaunoy M, Farinotti R. Bonhomme-Faivre L, et al. Am J Health Syst Pharm. 2009 Sep 15;66(18):1645-51. doi: 10.2146/ajhp080396. Am J Health Syst Pharm. 2009. PMID: 19729569

3

Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.

Bonhomme-Faivre L, Benyamina A, Reynaud M, Farinotti R, Abbara C. Bonhomme-Faivre L, et al. Addict Biol. 2008 Sep;13(3-4):295-300. doi: 10.1111/j.1369-1600.2008.00096.x. Epub 2008 Mar 7. Addict Biol. 2008. PMID: 18331373

4

Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence.

Benyamina A, Bonhomme-Faivre L, Picard V, Sabbagh A, Richard D, Blecha L, Rahioui H, Karila L, Lukasiewicz M, Farinotti R, Picard V, Marill C, Reynaud M. Benyamina A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1270-4. doi: 10.1016/j.pnpbp.2009.07.016. Epub 2009 Jul 20. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19625010

5

MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer.

Paule B, Castagne V, Picard V, Saffroy R, Adam R, Guettier C, Farinotti R, Bonhomme-Faivre L. Paule B, et al. Med Oncol. 2010 Dec;27(4):1066-72. doi: 10.1007/s12032-009-9336-3. Epub 2009 Oct 28. Med Oncol. 2010. PMID: 19862647

6

Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice.

Bonhomme-Faivre L, Pelloquin A, Tardivel S, Urien S, Mathieu MC, Castagne V, Lacour B, Farinotti R. Bonhomme-Faivre L, et al. Anticancer Drugs. 2002 Jan;13(1):51-7. doi: 10.1097/00001813-200201000-00006. Anticancer Drugs. 2002. PMID: 11914641

7

Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.

Castagne V, Bonhomme-Faivre L, Urien S, Ben Reguiga M, Soursac M, Gimenez F, Farinotti R. Castagne V, et al. Drug Metab Dispos. 2004 Feb;32(2):168-71. doi: 10.1124/dmd.32.2.168. Drug Metab Dispos. 2004. PMID: 14744937

8

Modification of the P-glycoprotein dependent pharmacokinetics of digoxin in rats by human recombinant interferon-alpha.

Ben Reguiga M, Bonhomme-Faivre L, Orbach-Arbouys S, Farinotti R. Ben Reguiga M, et al. Pharm Res. 2005 Nov;22(11):1829-36. doi: 10.1007/s11095-005-7415-5. Epub 2005 Aug 16. Pharm Res. 2005. PMID: 16151670

9

Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats.

Ben Reguiga M, Bonhomme-Faivre L, Farinotti R. Ben Reguiga M, et al. J Pharm Pharmacol. 2007 Mar;59(3):401-8. doi: 10.1211/jpp.59.3.0010. J Pharm Pharmacol. 2007. PMID: 17331344

10

Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.

Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D. Sebagh M, et al. Liver Transpl. 2011 Jul;17(7):798-808. doi: 10.1002/lt.22282. Liver Transpl. 2011. PMID: 21351239 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters